EP2851056A1 - Distributeur de médicaments - Google Patents

Distributeur de médicaments Download PDF

Info

Publication number
EP2851056A1
EP2851056A1 EP20130185270 EP13185270A EP2851056A1 EP 2851056 A1 EP2851056 A1 EP 2851056A1 EP 20130185270 EP20130185270 EP 20130185270 EP 13185270 A EP13185270 A EP 13185270A EP 2851056 A1 EP2851056 A1 EP 2851056A1
Authority
EP
European Patent Office
Prior art keywords
chamber
screw threads
medication
dispenser
breakable membrane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP20130185270
Other languages
German (de)
English (en)
Other versions
EP2851056B1 (fr
Inventor
Rourke Yeakley
Charles L. Floyd
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to EP13185270.9A priority Critical patent/EP2851056B1/fr
Publication of EP2851056A1 publication Critical patent/EP2851056A1/fr
Application granted granted Critical
Publication of EP2851056B1 publication Critical patent/EP2851056B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2089—Containers or vials which are to be joined to each other in order to mix their contents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/06—Ampoules or carpules
    • A61J1/067—Flexible ampoules, the contents of which are expelled by squeezing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/10—Bag-type containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/202—Separating means
    • A61J1/2027—Separating means having frangible parts

Definitions

  • the presently disclosed and claimed inventive concepts generally relate to an apparatus for administering medication, and more particularly to premeasured dosing of medication.
  • medication to be dispensed in small amounts is often sold in large containers and sent in shipments that may require refrigeration.
  • the cost of a relatively small amount of medication is increased by the cost of transporting the medication to the desired location and storing the medication.
  • the individual needing to use medication is required to purchase a greater amount of medication than is actually needed. In these circumstances the cost of the more-than-needed medication can be prohibitive for the individual.
  • the administration of medication often requires more time, knowledge, or precision than an individual is able to apply to the administration of medication. When this occurs, an individual could measure and utilize the medication inappropriately. As a result, individuals may become ill from taking too much of the medication or find that the medication is ineffective against the disease to be treated when improperly-small dosages of the medications are administered. This in turn can lead to a variety of otherwise-avoidable health issues including sickness, discomfort, pain, irritability, and even death to individuals who fail to take the proper medication at the proper times or in the proper amounts.
  • the present dispenser is a dispensing system for dispensing pre-measured doses of selected materials, particularly medications, in a safe and effective manner and in any of a variety of circumstances.
  • the dispenser can be utilized by individuals with little to no medical training and without the need to measure medications to be dispensed.
  • the dispenser includes a first chamber containing a first fluid, such as a reconstituting liquid, and a second chamber containing a second material, such as a medication powder.
  • the first chamber has first screw threads lining an external area.
  • the first chamber further has an open top end that is covered by a breakable membrane. For additional protection during transport the breakable membrane may be covered by a breakaway tab. The breakaway tab is removed by a user prior to use.
  • the second chamber has second screw threads lining an internal area.
  • the second chamber further has a break-off tip, which, when removed defines an opening.
  • Contained within the second chamber is a breaker ring having a lower edge configured to break the breakable membrane.
  • the second chamber further has a plug that creates a seal with the breaker ring. This plug prevents contamination getting into the container and prevents material within the container from getting around the lower edge of the breaker ring and occupying the space between the breaker ring and the second screw threads.
  • the first and second screw threads are configured to interact with one another such that the first and second chambers can be joined via the screw threads.
  • the first chamber and second chamber are twistable, relative to one another, to move the chambers closer to or further away from one another.
  • the first chamber and second chamber are to be twisted into an extended position in which the lower edge of the breaker ring is situated so as to be above the breakable membrane.
  • the first chamber and second chamber can then be twisted relative to each other to bring the lower edge of the breaker ring into forced contact with the breakable membrane, eventually resulting in breakage of the breakable membrane. Additional twisting of the first chamber and second chamber relative to one another transitions the dispenser to a compact position. In the compact position the first fluid within the first chamber and the second material within the second chamber are able to join into a mixture. When the break-off tip is removed, the mixture can be forced out of the dispenser to be administered to a patient.
  • the two chambers of the dispenser can be unconnected from one another and the material within the second chamber, which could be medication in a powder form, dispensed by removing the plug and emptying the second chamber via the open bottom end of the chamber, without having to open the break-off tip.
  • the material within the first chamber can be separately dispensed, when the two chambers of the dispenser are unconnected, by breaking the breakable membrane and emptying the contents of the first chamber via the open top end of the first chamber.
  • this dispenser allows a pre-measured dosage of medication to be administered without having to use separate medication delivery devices and without the necessity of separately or carefully measuring the material to be dispensed. Having the material to be dispensed contained within one device lessens the risk of spillage and waste of the material. Further, the dispenser is used with only easy manipulation of a simple and safe device as no external sharp objects need be utilized. Thus, the dispenser can be utilized in a broad variety of circumstances by individuals with little or no training, either in medicine or in use of the dispenser.
  • Figure 1 is an elevation view of the front of a medication dispenser according to a an embodiment of a dispensing system including broken lines to illustrate the internal components of the embodiment.
  • Figure 2 is an elevation view of the right side of a medication dispenser according to an embodiment of a dispensing system including broken lines to illustrate the internal components of the embodiment.
  • Figure 3 is an elevation view of the front of a first chamber of a medication dispenser according to an embodiment of the invention.
  • Figure 4 is an elevation view of the right side of a first chamber of a medication dispenser according to an embodiment of a dispensing system.
  • Figure 5 is an elevation view of a front of a medication dispenser according to an embodiment of a dispensing system.
  • Figure 6 is an elevation view of a right side of a medication dispenser according to an embodiment of a dispensing system.
  • Figure 7 is a cross-sectional, elevation view of the break-off tip, and plug of a medication dispenser according to an embodiment of a dispensing system.
  • Figure 8 is an isometric view of a plug according to an embodiment of a dispensing system.
  • Figure 9 is an isometric view of a break-off tip after removal from a second chamber according to an embodiment of a dispensing system.
  • embodiments of the dispensing system provide a system for storing, transporting, and eventually dispensing a pre-measured amount of a mixture of material, such as a medication mixture, where such mixture is originally stored in two separated containers.
  • a mixture of material such as a medication mixture
  • medication in a solid, powder form can be kept separate from a reconstituting fluid, but in containers quickly and easily combined to provide for mixture of the substances before dispensing of the same without having to use separate dispensing devices and without having to have medical or technological training.
  • the dispensing system includes a dispenser 12.
  • the dispenser 12 includes a first chamber 26 that has an open top end 24.
  • First screw threads 36 line an upper area of the first chamber 26's external surface 22.
  • the first chamber 26 is at least partially compressible, preferably laterally compressible.
  • the first chamber 26 contains a first material, such as a fluid.
  • the first material is a fluid, specifically a reconstituting fluid.
  • the reconstituting fluid is a liquid such as water.
  • the reconstituting fluid is a gas such as air.
  • the open top end 24 is covered by a breakable membrane 30 (shown in Figure 4 ).
  • the breakable membrane 30 closes off the open top end 24 so that the reconstituting fluid is contained within the first chamber 26.
  • the breakable membrane 30 is further covered by a removable tab. A removable tab provides additional protection to breakable membrane 30 during transport and prevents accidental connection of the chambers 26, 28.
  • the dispenser 12 of the depicted embodiments further includes a second chamber 28 that has an open bottom end.
  • Second screw threads 46 line a lower area of the second chamber 28's internal surface.
  • the second screw threads 46 are recessed within the wall of the second chamber 28. This minimizes the bulk of the second chamber 28 and thus the bulk of the dispenser 12 itself.
  • Contained within the second chamber 28 is a second material, preferably the second material is a medication, preferably in a solid, powder farm. In other embodiments, the second material is a second fluid, such as a medication in liquid form.
  • the second chamber 28 further includes a break-off tip 16 (shown in Figure 7 ) that is broken off by a user to form an opening, preferably at the upper-most portion of the second chamber 28.
  • the break-off tip 16 uses a ring 60 attached to the break-off tip 16 to allow a user to insert a finger for improved leverage, alternatively, a solid flat disc can be used to allow a user to grasp the disc and twist until the tip breaks away from the dispenser, or other suitable devices can be used.
  • the second chamber 28 can be configured to allow administration of the desired medication through either oral or nasal pathways once the break-off tip 16 is removed.
  • the dispenser 12 further includes a breaker ring 40 within the second chamber 28, situated above the second screw threads 46.
  • plug 56 is included (as shown in Figure 7 ).
  • Plug 56 can be configured to screw into second screw threads 46, press-fit into open bottom end 38 and held by friction, or other means of adhering plug 56 within open bottom end 38.
  • Plug 56 is configured to prevent contamination of the second material by external matter and to prevent travel of the second material from inside said second chamber 28, around the lower edge and into the space between said breaker ring 40 and second screw threads 46.
  • the plug 56 is a long cylindrical member 58 having a length great enough to extend from the open bottom end 30 to breaker ring 40. Cylindrical member 58 as a diameter large enough to fully cover breaker rind 40. In one embodiment, cylindrical member 58 is held in place by friction with second screw threads 46. As one possible alternative, cylindrical member 58 is held to breaker ring 40 through suction. In another embodiment, cylindrical member 58 has third screw threads on its exterior which interact with second screw threads 46 to hold cylindrical member 58 in place.
  • the second screw threads 46 of the second chamber 28 are configured to correspond with the first screw threads 36 of the first chamber 26 such that the second chamber 28 and first chamber 26 are configured to be selectively joinable to one another via interaction of the first screw threads 36 and second screw threads 46 (see figure 1 ).
  • the first chamber 26 and second chamber 28 are configured to be selectively disconnected from one another via interaction of the first screw threads 36 and the second screw threads 46.
  • the screw threads 36, 46 are configured such that a clockwise rotation of the first chamber 26 relative to the second chamber 28 will draw the two chambers 26, 28 into closer proximity with one another while a counterclockwise rotation of the first chamber 26 relative to the second chamber 28 will move the two chambers 26, 28 further away from one another, eventually disconnecting the chambers 26, 28 from one another.
  • twisting the second chamber 28 relative to the first chamber 26 to join the two together effectively closes the second chamber 28 to prevent the material within, such as a medication, from leaving the dispenser 12.
  • first chamber 26 and second chamber 28 are joined and arranged in an extended position, shown in Figures land 2, in which the narrow lower edge of the breaker ring 40 is external to the second chamber 28 and is not in contact with the breakable membrane 30.
  • the first chamber 26 and second chamber 28 are further twistable, relative to one another, via interaction of the second screw threads 46 and first screw threads 36, so that the second chamber 28 and first chamber 26 are brought into closer proximity to one another. Enough twisting eventually transitions the dispenser 12 to a compact position, shown in Figure 5 . In the compact position, the narrow lower edge of the breaker ring 40 is received within the open top end 24 of the first chamber 26.
  • the narrow lower edge of the breaker ring 40 is brought into forced contact with the breakable membrane 30 covering the open top end 24 of the first chamber 26. Additional twisting results in the narrow lower edge breaking the breakable membrane 30.
  • the breakable membrane 30 is broken, the first chamber 26 and second chamber 28 form a joined chamber within the dispenser 12. Accordingly, the medication that was originally contained within the second chamber 28 and the reconstituting fluid 32 that was originally contained with the first chamber 26 can mix and form a medication mixture. Ideally, the medication may be shaken or otherwise agitated to encourage mixing of the medication and reconstituting fluid 32 between the two chambers 26, 28.
  • first screw threads 36 of the first chamber 26 and the second screw threads 46 of the second chamber 28 are configured to form a fluid-tight seal so that, once the breakable membrane 30 is broken, none of the reconstituting fluid 32 or medication mixture will unintentionally leave the dispenser 12.
  • the breaker ring 40 of the first depicted embodiment, shown in Figure 6 includes a narrow lower edge that is smooth and even along its edge.
  • the narrow lower edge defines a lower plane that is essentially parallel to an upper plane defined by the wide upper edge.
  • Such lower plane and upper plane are also essentially parallel to the middle plane defined by the peripheral protrusion.
  • the breaker ring 40 of an alternative embodiment includes a narrow lower edge that has a protruding member.
  • the protruding member is configured to break the breakable membrane 30 upon forced contact with the breakable membrane 30.
  • the protruding member is a sharp point.
  • forced contact of the tip of the sharp point with the breakable membrane 30 will result in first a puncturing of the breakable membrane 30 followed by a general breakage of the breakable membrane 30 as the breaker ring 40 is brought into further forced contact with the breakable membrane 30 as the first chamber 26 and second chamber 28 are twisted relative to one another.
  • the breaker ring 40 includes a number of protruding members along the narrow lower edge.
  • the breaker ring 40 of an alternative embodiment includes a narrow lower edge that is smooth and even along its edge. Further the narrow lower edge defines a lower plane that is not parallel to an upper plane defined by the wide upper edge Rather, the narrow lower edge of the breaker ring 40, according to the third depicted embodiment, slants such that one area of the narrow lower edge will come into contact with the breakable membrane 30 first, before the other areas of the narrow lower edge as the dispenser 12 is transitioned between the extended position and the compact position. As such, the forced interaction of the narrow lower edge and the breakable membrane 30 will, at least at first, be concentrated on the lowest area of the narrow lower edge , encouraging breakage of the breakable membrane 30 in that area of contact.
  • the break-off tip 16 can be removed so as to form an opening 34. Thereafter, the first chamber 26 may be compressed so as to force the medication mixture out of the first chamber 26, through the breaker ring 40, and out of the second chamber 28 via the opening 34. In some situations, the first chamber 26 is compressed due to physical squeezing of the first chamber 26. In other situations, the first chamber 26 is compressed due to the application of suction within the dispenser 12.
  • the dispenser 12 is further configured such that the material within the first chamber 26 can be dispensed without removing the break-off tip 16. That is, the first chamber 26 and second chamber 28 can be selectively disconnected from one another via twisting in the opposite direction that one would twist to transition the dispenser 12 from the extended position to the compact position. This twisting will eventually separate the two chambers 26, 28 from each other. Thereafter, the material within the second chamber 28, such as the medication, can be emptied via the open bottom end 38.
  • the breakable membrane 30 can be broken with means other than the breaker ring 40, such as by application of pressure with a finger or fingernail against the breakable membrane 30 or with the use of a separate puncturing device, so as to make accessible the open top end 24.
  • the material within the first chamber 26 can be emptied via the open top end 24. Accordingly, separation of the two chambers 26, 28 from one another provides an option for dispensing of the medication to a patient without mixing the materials contained separately in chamber 26 and chamber 28. Further, the separation of the two chambers 26, 28 allows a user to refill or replace material within one or the other chamber 26, 28 before or without mixing the materials.
  • the medication within the second chamber 28 is a solid powder. In other embodiments, the medication is in fluid form. In still other embodiments, the material within the second chamber 28 is a non-medicinal material. Further, according to the depicted embodiments, the second chamber 28 is made up of a translucent plastic that is noncompressible. Also according to the depicted embodiments, the first chamber 26 tapers in width along the lower part of the first chamber 26 such that the open top end 24 is broader than the bottom edge 52. In this way, the tapering section forms a handle. As it is preferred that the first chamber 26 be compressible, according to the depicted embodiments, the first chamber 26 is preferably compressible laterally, such that the individual dispensing the medication would squeeze along the tapering area.

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
EP13185270.9A 2013-09-20 2013-09-20 Distributeur de médicaments Active EP2851056B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP13185270.9A EP2851056B1 (fr) 2013-09-20 2013-09-20 Distributeur de médicaments

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP13185270.9A EP2851056B1 (fr) 2013-09-20 2013-09-20 Distributeur de médicaments

Publications (2)

Publication Number Publication Date
EP2851056A1 true EP2851056A1 (fr) 2015-03-25
EP2851056B1 EP2851056B1 (fr) 2016-08-03

Family

ID=49253104

Family Applications (1)

Application Number Title Priority Date Filing Date
EP13185270.9A Active EP2851056B1 (fr) 2013-09-20 2013-09-20 Distributeur de médicaments

Country Status (1)

Country Link
EP (1) EP2851056B1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114025726A (zh) * 2019-04-24 2022-02-08 克里斯蒂娜.莫里森 具有用于分配治疗流体的内腔室的施用装置

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3404811A (en) * 1966-12-02 1968-10-08 Cernei Jose Container for maintaining in separate condition liquids which are to be mixed together and which may be manipulated to commingle such liquids
US4632244A (en) * 1986-02-19 1986-12-30 Boris Landau Multiple chamber flexible container
WO2004031051A1 (fr) * 2002-10-03 2004-04-15 Sealants International Limited Systeme de contenant de tubes
US20060289316A1 (en) * 2005-06-27 2006-12-28 Henry John R Mixing container
US20110178494A1 (en) * 2010-01-18 2011-07-21 Yeakley Rourke M Twistable medication dispensing system
US20110178459A1 (en) * 2010-01-18 2011-07-21 Yeakley Rourke M Multi-Chamber Mixture Dispensing System

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3404811A (en) * 1966-12-02 1968-10-08 Cernei Jose Container for maintaining in separate condition liquids which are to be mixed together and which may be manipulated to commingle such liquids
US4632244A (en) * 1986-02-19 1986-12-30 Boris Landau Multiple chamber flexible container
WO2004031051A1 (fr) * 2002-10-03 2004-04-15 Sealants International Limited Systeme de contenant de tubes
US20060289316A1 (en) * 2005-06-27 2006-12-28 Henry John R Mixing container
US20110178494A1 (en) * 2010-01-18 2011-07-21 Yeakley Rourke M Twistable medication dispensing system
US20110178459A1 (en) * 2010-01-18 2011-07-21 Yeakley Rourke M Multi-Chamber Mixture Dispensing System

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114025726A (zh) * 2019-04-24 2022-02-08 克里斯蒂娜.莫里森 具有用于分配治疗流体的内腔室的施用装置
US11571556B2 (en) 2019-04-24 2023-02-07 Christina Morrison Applicator with internal chambers for dispensing therapeutic fluids

Also Published As

Publication number Publication date
EP2851056B1 (fr) 2016-08-03

Similar Documents

Publication Publication Date Title
US8382737B2 (en) Multi-chamber mixture dispensing system
US9132950B1 (en) Extended twist blast
US7951109B2 (en) Liquid chamber cap with compartment for use with injectables
US8376988B2 (en) Device for packaging and sublingual administration of active principles
US7452350B2 (en) Pre-dosed oral liquid medication dispensing system
AU2010312289B2 (en) Inter vial transfer system
KR102450956B1 (ko) 성분들을 혼합 및 분배하기 위한 용기
KR102450955B1 (ko) 유체 약제 성분들을 혼합 및 분배하기 위한 용기
US8563013B2 (en) Systems and methods for delivering a fluid drug
US10023370B2 (en) Dispensing device having a peripheral outer wall
US7032787B2 (en) Integrated dispenser
JP2010509141A (ja) 蓋及び分注システム
US20190380910A1 (en) Device for packaging two products to be mixed and for dispensing the mixture of these products
US20180311110A1 (en) System For Dosing And Dispensing Medication
KR200469855Y1 (ko) 스포이드 결합형 분말 혼합 화장용기
WO2013091882A1 (fr) Emballage pharmaceutique
EP2851056B1 (fr) Distributeur de médicaments
US20220008289A1 (en) Pill capsule holding device for improved handling of sprinkle, powder, and granules medication
US8109917B2 (en) Twistable medication dispensing system
US20220088357A1 (en) Delivery systems and method thereof
US20150202372A1 (en) Syringe for the application of multiple topical treatments
US8361051B2 (en) Calibrated medicine mixing assembly and associated method
US20140350525A1 (en) E-Z Dose-Pensing
JP4894524B2 (ja) 簡易注出具
BG3281U1 (bg) Капсула за съхранение на продукт, предназначен за смесване с течен продукт в пластмасова бутилка

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20130920

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

R17P Request for examination filed (corrected)

Effective date: 20150923

RBV Designated contracting states (corrected)

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

RIC1 Information provided on ipc code assigned before grant

Ipc: A61J 1/20 20060101ALI20160303BHEP

Ipc: B65D 81/32 20060101ALI20160303BHEP

Ipc: A61J 1/10 20060101ALI20160303BHEP

Ipc: A61J 1/06 20060101AFI20160303BHEP

INTG Intention to grant announced

Effective date: 20160401

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

Ref country code: AT

Ref legal event code: REF

Ref document number: 816877

Country of ref document: AT

Kind code of ref document: T

Effective date: 20160815

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602013010012

Country of ref document: DE

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 4

REG Reference to a national code

Ref country code: CH

Ref legal event code: NV

Representative=s name: SORIN SCHNEITER IP PARTNERS, CH

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20160803

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 816877

Country of ref document: AT

Kind code of ref document: T

Effective date: 20160803

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160803

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161103

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160803

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161203

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160803

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160803

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160803

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160803

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160803

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20160930

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160803

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161205

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160803

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160803

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160803

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161104

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160803

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160803

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602013010012

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160803

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20161103

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160803

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160803

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160803

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160803

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160803

26N No opposition filed

Effective date: 20170504

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20160920

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160803

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20160920

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 5

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20130920

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160803

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160803

Ref country code: MT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20160930

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 6

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160803

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160803

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20180904

Year of fee payment: 6

Ref country code: FR

Payment date: 20180813

Year of fee payment: 6

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20180919

Year of fee payment: 6

REG Reference to a national code

Ref country code: CH

Ref legal event code: PCAR

Free format text: NEW ADDRESS: IP PARTNERS AVENUE DE RIOND-BOSSON 3, 1110 MORGES (CH)

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 602013010012

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200401

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20190920

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20190920

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20190930

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 20221001

Year of fee payment: 10

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20230930

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20230930